**Core Concept**
Type II paralysis in organophosphorus poisoning is a condition characterized by muscle weakness or paralysis due to the accumulation of acetylcholine in the neuromuscular junction. This occurs when the enzyme acetylcholinesterase (AChE) is inhibited, leading to an accumulation of acetylcholine (ACh) in the synaptic cleft.

**Why the Correct Answer is Right**
The correct treatment for Type II paralysis involves the administration of an anticholinergic agent, such as atropine, to counteract the excessive effects of acetylcholine at the neuromuscular junction. Atropine works by competitively inhibiting acetylcholine receptors, thereby reducing the muscle spasms and weakness associated with Type II paralysis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not address the underlying cause of Type II paralysis, which is the accumulation of acetylcholine in the neuromuscular junction.

**Option B:** This option is incorrect as it does not mention the specific mechanism of action of the treatment for Type II paralysis, which involves the inhibition of acetylcholine receptors.

**Option C:** This option is incorrect as it does not specify the type of anticholinergic agent used to treat Type II paralysis, which is a critical detail in the management of this condition.

**Clinical Pearl / High-Yield Fact**
The use of atropine in the treatment of Type II paralysis is a classic example of a "cholinergic crisis" in organophosphorus poisoning, where the goal is to counteract the excessive effects of acetylcholine at the neuromuscular junction.

**Correct Answer: A. Atropine**